Bioelectronics Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIEL research report →
About the company
BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions.
- CEO
- Kelly A. Whelan
- IPO
- 2004
- Employees
- 9
- HQ
- Frederick, MD, US
Price Chart
- Market Cap
- $5.42M
- P/E
- -7.96
- P/S
- 10.93
- P/B
- -0.43
- EV/EBITDA
- -53.34
- Div Yield
- 0.00%
- Gross Margin
- 73.32%
- Op Margin
- -79.17%
- Net Margin
- -187.62%
- ROE
- 5.49%
- ROIC
- 20.93%
- Revenue
- $496.03K · -30.60%
- Net Income
- $-930,650 · -28.75%
- EPS
- $0.00 · 0.00%
- Op Income
- $-392,689
- FCF YoY
- 51.14%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 2.01
- Avg Volume
- 17.32M
Get TickerSpark's AI analysis on BIEL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our BIEL coverage
Recent articles, reports, and earnings notes.
No research on BIEL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BIEL report →Similar companies
Peers in the same neighborhood.